University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer.


  1. Home


  2. Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer.


  3. Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer.

rakerr2

Carlson JJ, Italiano A, Brose MS, Federman N, Lassen U, Kummar S, Sullivan SD. Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer. Am J Manag Care. 2022 Jan;28(2 Suppl):S26-S32. doi: 10.37765/ajmc.2022.88845. Review.

Upcoming Events

Full Calendar

News Categories